Skip to main content
OpenTrials
Completed

NCT Number: NCT01034150

Effects of Home-based Neurostimulation Associated With Motor Training in Chronic Stroke Patients

Objective: To investigate effects of home-based somatosensory stimulation associated with motor training on improvement in performance of the paretic upper extremity in patients in the chronic phase after stroke.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1 / Phase 2

Primary location

University of São Paulo/General Hospital

São Paulo, 55, Brazil

About this study

Design: Double-blind, randomized, controlled clinical trial. Setting: Home-based rehabilitation. Subjects: Patients in the chronic phase (> 6 months) after stroke. Interventions: Patients will be randomized to an active and a control group. In both groups, treatments will be performed at home, daily, over four weeks. Patients in the active group will be instructed to use a device that provides somatosensory stimulation in the form of electrical stimulation of the median nerve for two hours. Patients in the control group will also be instructed to use the device for two hours, and sham stimulation will be administered. In both groups, patients will be instructed to train activities with the paretic hand immediately after nerve stimulation.

Main measures: The primary outcome will be improvement in performance of the paretic hand evaluated by the Jebsen-Taylor test at end of treatment and four months after end of treatment, compared to baseline. Secondary outcomes were: 1) Compliance with the interventions, assessed through a daily written log, and oral reports of the patients; 2) safety profile of the interventions.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age 18-80 years;
  • single ischemic or hemorrhagic stroke in a cerebral hemisphere, documented by computed tomography (CT) or magnetic resonance imaging (MRI);
  • stroke onset at least six months before;
  • hand paresis with preserved ability to perform all tasks of the Jebsen-Taylor Test (JTT).

Exclusion criteria

  • previous strokes;
  • epilepsy and other neurological conditions;
  • proprioceptive or tactile anesthesia;
  • shoulder or hand pain;
  • severe joint deformity;
  • severe chronic disease;
  • inability to give provide informed consent due to severe aphasia or cognitive impairment;
  • left handedness before the stroke.

Treatment and study plan

Relief band (Somatosensory stimulation)

Device

Electrical median nerve stimulation

Other names: Relief band

Placebo stimulation

Device

Placebo stimulation

Other names: no stimulation

Primary outcomes

  1. the improvement in upper extremity performance assessed using Jebsen-Taylor test

    Time frame: Treatment lasted four weeks. Measures were performed before the treatment, immediately after the treatment and four months after the end of the treatment

Secondary outcomes

  1. Compliance with the interventions, assessed through a daily written log, and oral reports of the patients

    Time frame: immediately after the treatment

  2. Adverse events

    Time frame: at end of treatment

Sponsors and collaborators

Lead sponsor

University of Sao Paulo General Hospital

Other

Collaborators

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fundação de Amparo à Pesquisa do Estado de São Paulo

Registry information

Important dates

Study start
2007
Primary completion
2009
Study completion
2009
First posted
Dec 17, 2009
Registry last updated
Dec 17, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.